Sweden· SE-20251113000065
Zolmitriptan Abacus Medicine 5 mg Tablett
A zolmitriptan product, registered in Sweden by Abacus Medicine A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Zolmitriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC03 (zolmitriptan), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 9 of them publish a price we can compare per daily dose
Zolmitriptan · ATC N02CC03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zolmitriptan costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.05 in France to $7.21 in Switzerland — a ×6.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Zolmitriptan · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.21
- IT Italy$2.58
- FR France$1.05
The record
At a glance
Swedish Medical Products Agency (Sweden)- Manufacturer
- Abacus Medicine A/S
- Country
- Sweden (SE)
- ATC code
- N02CC03
- ATC class
- Zolmitriptan
- Defined daily dose
- 2.5 mg, N
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20251113000065
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for zolmitriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zolmitriptan · interactions on record
114 records
- 11 severe
- 25 moderate
- 5 minor
- 72 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N02CC03
Zolmitriptan, as other registers publish it.
- GermanyAscotopGrünenthal Gmbh
- GermanyAscotop NasalGrünenthal Gmbh
- CanadaAURO-ZOLMITRIPTANAURO PHARMA INC
- CanadaBIO-ZOLMITRIPTANBIOMED PHARMA
- ItalyHEADZOLLANOVA FARMACEUTICI S.R.L.
- CanadaJAMP-ZOLMITRIPTANJAMP PHARMA CORPORATION
- CanadaMINT-ZOLMITRIPTANMINT PHARMACEUTICALS INC
- CanadaNAT-ZOLMITRIPTANNATCO PHARMA (CANADA) INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/69890ff1-4652-41c4-b551-3f2b42389172 GET /v1/drugs/69890ff1-4652-41c4-b551-3f2b42389172?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20251113000065",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20251113000065",
"product_doc_link": "https://docetp.mpa.se/LMF/Zolmitriptan%20Abacus%20Medicine%205%20mg%20tablet%20DE%20PL_09001bee84f7388d.pdf"
}See everything about zolmitriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.